- Open
- 14.50
- High
- 14.75
- Low
- 14.00
- Close
- 14.09
- Change
- -0.50 (-3.45%)
- Volume
- 617,206
⌘K
| 28 May 2026 | 14:35:10 | Holding(s) in Company |
| 22 May 2026 | 10:11:00 | Result of Placing |
| 22 May 2026 | 07:02:00 | Proposed Placing to raise approximately £5.5m |
| 22 May 2026 | 07:01:01 | FY25 Final Results |
| 11 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 3 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jun 2023 | Annual Report and Accounts (to 2022-12-31) |
Creo Medical is a company that specializes in creating medical devices that use advanced energy to perform minimally invasive electrosurgery during endoscopic procedures.
| 28 May 2026 | 14:35:10 | Holding(s) in Company |
| 22 May 2026 | 10:11:00 | Result of Placing |
| 22 May 2026 | 07:02:00 | Proposed Placing to raise approximately £5.5m |
| 22 May 2026 | 07:01:01 | FY25 Final Results |
| 11 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 3 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jun 2023 | Annual Report and Accounts (to 2022-12-31) |
Creo Medical is a company that specializes in creating medical devices that use advanced energy to perform minimally invasive electrosurgery during endoscopic procedures.
| 22 May 2026 |
| 07:00:06 |
| Proposed Sale of 49% Interest in Creo Medical SL |
| 22 May 2026 |
| Creo Medical shares surge 27% on proposed sale of remaining European stake |
| 22 May 2026 | Creo Medical shares surge 27% on proposed sale of remaining European stake |
| 22 May 2026 | Creo Medical Group to raise £5.5m and advance partial divestment |
| 22 Jul 2025 | Creo Medical — H1 momentum underpins FY25 confidence |
| 11 Jun 2025 | Creo Medical — SpydrBlade Flex set to enter the US market |
| 27 May 2025 | Creo Medical — Rightsized and refocused |
| 22 May 2026 |
| 07:00:06 |
| Proposed Sale of 49% Interest in Creo Medical SL |
| 22 May 2026 |
| Creo Medical shares surge 27% on proposed sale of remaining European stake |
| 22 May 2026 | Creo Medical shares surge 27% on proposed sale of remaining European stake |
| 22 May 2026 | Creo Medical Group to raise £5.5m and advance partial divestment |
| 22 Jul 2025 | Creo Medical — H1 momentum underpins FY25 confidence |
| 11 Jun 2025 | Creo Medical — SpydrBlade Flex set to enter the US market |
| 27 May 2025 | Creo Medical — Rightsized and refocused |